| Authors: |
Nitani C; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan. c-tanaka@med.osakacity-hp.or.jp., Hara J; Department of Pediatric Hematology and Oncology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-Ku, Osaka, 534-0021, Japan., Kawamoto H; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Taguchi T; Pediatric Surgery, Kyushu University Hospital, Fukuoka, Japan., Yuza Y; Department of Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan., Karakawa S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan., Matsumoto K; Children Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Kimura T; Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Juntendo University, Tokyo, Japan., Yoshimura K; Department of Biostatistics, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan., Yoshimura K; Department of Clinical Immuno-Oncology, Clinical Research Institute of Clinical Pharmacology and Therapeutics, Showa University, Tokyo, Japan., Hamada A; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan. |
